Although the specific function of the two separate bromodomains BD1 and BD2 of transcription initiation factor TFIID subunit 1 (TAF1) remains ambiguous, they are recognized as potential targets for tumor therapy [206]. This evidence concerns the gene TAF1 and neoplasm.